EXHIBIT 10.39 ----- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. THIS AGREEMENT dated 4 May 2001 (the "EFFECTIVE DATE") is made BETWEEN: (1) ISIS INNOVATION LIMITED,...Agreement • November 13th, 2001 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 13th, 2001 Company Industry
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 13th, 2002 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 13th, 2002 Company Industry
UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • June 5th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 5th, 1998 Company Industry Jurisdiction
andAsset Purchase Agreement • August 28th, 2001 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 28th, 2001 Company Industry
WHEREAS, Vitex and Bayer entered into a First Amended and Restated Agreement for Custom Processing dated January 24, 1996 (the "Custom Processing ----------------- Agreement"), pursuant to which Bayer agreed to supply plasma to Vitex and Vitex...Settlement Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
Page SECTION 1. DEFINITIONS..................................................... 1 1.1 Defined Terms...................................................... 1 1.2 Other Definitional Provisions...................................... 16 SECTION 2. AMOUNT...Credit Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
PARTIESEmployment Agreement • February 26th, 1998 • V I Technologies Inc • New York
Contract Type FiledFebruary 26th, 1998 Company Jurisdiction
EXHIBIT 2.1 ------------Agreement and Plan of Merger • November 10th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 10th, 1999 Company Industry Jurisdiction
NON-EXCLUSIVE LICENSE AGREEMENT (#2) FOR UV TREATED BLOOD DERIVED THERAPEUTIC PRODUCTS between THE NEW YORK BLOOD CENTER, INC. and MELVILLE BIOLOGICS, INC. -----------------------------------------V I Technologies Inc • March 12th, 1998 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 12th, 1998 Industry Jurisdiction
EXHIBIT 10.42 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. MARKETING RIGHTS, DEVELOPMENT, ROYALTY, REVOLVING CREDIT AND SECURITY AGREEMENTAssignment Agreement • August 13th, 2002 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 13th, 2002 Company Industry Jurisdiction
LEASE BetweenV I Technologies Inc • March 12th, 1998 • Biological products, (no disgnostic substances)
Company FiledMarch 12th, 1998 Industry
Exhibit 10.1 ------------ SEPARATION AGREEMENT AND GENERAL RELEASE ---------------------------------------- Separation Agreement and General Release ("Agreement") executed this ___ day of September 1999, by and between Bernard Horowitz, Ph.D. ("Dr....Separation Agreement • November 15th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 15th, 1999 Company Industry Jurisdiction
RECITALSSublease Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 12th, 1998 Company Industry
WITNESSETH: ---------- WHEREAS, pursuant to the Credit Agreement, dated as of December 22, 1997 (the "Credit Agreement"), between the Company and Chase, Chase has agreed to make a term loan (the "Chase Term Loan") in the principal amount of...Intercreditor Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
MODIFICATION AGREEMENT ----------------------Modification Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
BY AND AMONGAgreement and Plan of Merger and Reorganization • October 7th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 7th, 1999 Company Industry Jurisdiction
SECURITY AGREEMENT ------------------ THIS AGREEMENT is made and entered into as of this 22d day of December, 1997, by and between V.I. Technologies, Inc. (formerly known as Melville Biologics, Inc.), a Delaware corporation with offices at 155 Duryea...Security Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
EXHIBIT 10.34 OPTION, DEVELOPMENT, MANUFACTURE AND LICENSE AGREEMENTLicense Agreement • October 7th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledOctober 7th, 1999 Company Industry Jurisdiction
REGISTRATION RIGHTS AGREEMENT dated February 19, 1998, among V.I. TECHNOLOGIES, INC., a Delaware corporation (the "Company"), and the stockholders of the Company listed on Schedule I (the "Investors").Registration Rights Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
indicates material omitted and filed separately with the Securities and Exchange Commission Pursuant to a request for confidential treatment.] second installment of ***************************** due no later than April 1, **** and a Third Installment...Exclusive License Agreement • March 31st, 2000 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2000 Company Industry
made byGuarantee and Collateral Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
EXHIBIT 10.31 MORTGAGE AND SECURITY AGREEMENTMortgage and Security Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
EXHIBIT 10.33 V.I. TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT ------------------------- This Agreement dated ______________________ is between V.I. Technologies, Inc. (the "Company"), a Delaware corporation, and ______________________ (the...Indemnification Agreement • February 26th, 1998 • V I Technologies Inc • Delaware
Contract Type FiledFebruary 26th, 1998 Company Jurisdiction
AGREEMENT ---------Agreement • February 26th, 1998 • V I Technologies Inc
Contract Type FiledFebruary 26th, 1998 Company
RECITALSLease Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 12th, 1998 Company Industry
EXCLUSIVE DISTRIBUTION AGREEMENT BY AND BETWEEN V.I. TECHNOLOGIES, INC. AND UNITED STATES SURGICAL CORPORATION EFFECTIVE OCTOBER 4, 1996Exclusive Distribution Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
EXHIBIT 10.14 -------------Omnibus Agreement • March 31st, 2000 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2000 Company Industry
BETWEENMarketing and Distribution Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 12th, 1998 Company Industry Jurisdiction
STOCK PURCHASE WARRANT To Purchase Shares of Common Stock ofV I Technologies Inc • December 15th, 2003 • Biological products, (no disgnostic substances)
Company FiledDecember 15th, 2003 IndustryTHIS STOCK PURCHASE WARRANT CERTIFIES that, for value received, $ (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 5, 2003 (the “Initial Exercise Date”) and on or prior to the close of business on December 5, 2007 (the “Termination Date”) but not thereafter, to subscribe for and purchase from V.I. Technologies, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $1.32, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certa
DEVELOPMENT AND SUPPLY AGREEMENT BETWEEN V.I. TECHNOLOGIES, INC. AND HAEMONETICS CORPORATIONV I Technologies Inc • November 13th, 2001 • Biological products, (no disgnostic substances) • Massachusetts
Company FiledNovember 13th, 2001 Industry Jurisdiction
SUFFOLK COUNTY INDUSTRIAL DEVELOPMENT AGENCY (SUFFOLK COUNTY, NEW YORK) andFacility Lease Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 12th, 1998 Company Industry
Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE ---------------------------------------- Separation Agreement and General Release ("Agreement") executed this ___ day of September 1999, by and between Bernard Horowitz, Ph.D. ("Dr. Horowitz" or...Separation Agreement and General • February 22nd, 2000 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 22nd, 2000 Company Industry Jurisdiction
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 22nd, 2005 • Panacos Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 22nd, 2005 Company Industry JurisdictionTHIS AGREEMENT is made and entered into this day of , 20 by and between PANACOS PHARMACEUTICALS, INC., a Delaware corporation (the “Corporation”), and (“Agent”). Its purpose is to provide the maximum protection for the Agent against personal liability arising out of his or her service to the Corporation so as to encourage the continuation of such service and the effective exercise of his or her business judgment in connection therewith.
SUFFOLK COUNTY INDUSTRIAL DEVELOPMENT AGENCY (Mortgagor) and MELVILLE BIOLOGICS, INC. (Company) to MILES INC. (Mortgagee)Mortgage, Security Agreement and Fixture Filing • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 12th, 1998 Company Industry